564 related articles for article (PubMed ID: 23873857)
21. Impact of percutaneous femoral arteriotomy closure using the MANTA
De Palma R; Settergren M; Rück A; Linder R; Saleh N
Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
[TBL] [Abstract][Full Text] [Related]
22. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
[TBL] [Abstract][Full Text] [Related]
23. A simple percutaneous technique for hemostasis and closure after transcatheter aortic valve implantation.
Badawi RA; Collins TJ; Ramee SR
Catheter Cardiovasc Interv; 2012 Jan; 79(1):152-5. PubMed ID: 21990123
[TBL] [Abstract][Full Text] [Related]
24. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
Pendyala LK; Minha S; Barbash IM; Torguson R; Magalhaes MA; Okubagzi P; Loh JP; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jan; 113(2):342-7. PubMed ID: 24220281
[TBL] [Abstract][Full Text] [Related]
25. Use of an ePTFE-covered nitinol self-expanding stent graft for the treatment off pre-closure device failure during transcatheter aortic valve replacement.
Steinvil A; Bernardo N; Rogers T; Koifman E; Buchanan K; Alraies MC; Shults C; Torguson R; Okubagzi PG; Pichard AD; Satler LF; Ben-Dor I; Waksman R
Cardiovasc Revasc Med; 2017 Mar; 18(2):128-132. PubMed ID: 27865711
[TBL] [Abstract][Full Text] [Related]
26. A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation.
Buchanan GL; Chieffo A; Montorfano M; Maccagni D; Maisano F; Latib A; Covello RD; Grimaldi A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2013 Mar; 81(4):579-83. PubMed ID: 22511470
[TBL] [Abstract][Full Text] [Related]
27. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
[TBL] [Abstract][Full Text] [Related]
28. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
30. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
Drafts BC; Choi CH; Sangal K; Cammarata MW; Applegate RJ; Gandhi SK; Kincaid EH; Kon N; Zhao DX
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1354-1362. PubMed ID: 29024382
[TBL] [Abstract][Full Text] [Related]
31. The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement.
Kiramijyan S; Magalhaes MA; Ben-Dor I; Koifman E; Escarcega RO; Baker NC; Torguson R; Okubagzi P; Bernardo NL; Satler LF; Pichard AD; Waksman R
EuroIntervention; 2016 May; 12(1):88-93. PubMed ID: 27173868
[TBL] [Abstract][Full Text] [Related]
32. A modified "preclosure" technique after percutaneous aortic valve replacement.
Kahlert P; Eggebrecht H; Erbel R; Sack S
Catheter Cardiovasc Interv; 2008 Nov; 72(6):877-84. PubMed ID: 19006257
[TBL] [Abstract][Full Text] [Related]
33. Management of vascular complications following transcatheter aortic valve implantation.
Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
[TBL] [Abstract][Full Text] [Related]
35. The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States.
Lardizabal JA; O'Neill BP; Desai HV; Macon CJ; Rodriguez AP; Martinez CA; Alfonso CE; Bilsker MS; Carillo RG; Cohen MG; Heldman AW; O'Neill WW; Williams DB
J Am Coll Cardiol; 2013 Jun; 61(23):2341-5. PubMed ID: 23583248
[TBL] [Abstract][Full Text] [Related]
36. Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation.
Frerker C; Schewel D; Kuck KH; Schäfer U
Catheter Cardiovasc Interv; 2013 Mar; 81(4):592-602. PubMed ID: 22707413
[TBL] [Abstract][Full Text] [Related]
37. Alternative access options for transcatheter aortic valve replacement in patients with no conventional access and chest pathology.
Al Kindi AH; Salhab KF; Roselli EE; Kapadia S; Tuzcu EM; Svensson LG
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):644-51. PubMed ID: 23537467
[TBL] [Abstract][Full Text] [Related]
38. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation.
Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C
EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222
[TBL] [Abstract][Full Text] [Related]
39. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
Fink N; Segev A; Barbash I; Bogdan A; Hamdan A; Mazin I; Maor E; Hay I; Guetta V; Fefer P
Catheter Cardiovasc Interv; 2016 Feb; 87(2):341-6. PubMed ID: 26010839
[TBL] [Abstract][Full Text] [Related]
40. Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety.
Mylotte D; Sudre A; Teiger E; Obadia JF; Lee M; Spence M; Khamis H; Al Nooryani A; Delhaye C; Amr G; Koussa M; Debry N; Piazza N; Modine T
JACC Cardiovasc Interv; 2016 Mar; 9(5):472-80. PubMed ID: 26965937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
